Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_5587_Библиотеки_им_академика_М_И_Перельмана.pdf

Importance of Applicability Domain of QSAR Models
Kar, S., & Roy, K. (2010). Predictive toxicology using QSAR: A perspective. Journal of the Indian
Chemical Society, 87, 1455–1515.
Manallack, D. T., Tehan, B. G., Gancia, E., Hudson, B. D., Ford, M. G., & Livingstone, D. J. etal.
(2003). A consensus neural network-based technique for discriminating soluble and poorly soluble
compounds. Journal of Chemical Information and Computer Sciences, 43(2), 674–679. doi:10.1021/
ci0202741 PMID:12653537
Mirkin, B. (2005). Clustering for data mining: A data recovery approach. London: Chapman & Hall/
CRC. doi:10.1201/9781420034912
Netzeva, T. I., Worth, A. P., Aldenberg, T., Benigni, R., Cronin, M. T. D., & Gramatica, P. etal. (2005).
Current status of methods for defining the applicability domain of (quantitative) structure-activity relationships. Alternatives to Laboratory Animals, 33(2), 155–173. PMID:16180989
Nikolova, N., & Jaworska, J. (2004). Approaches to measure chemical similarity-a review. QSAR &
Combinatorial Science, 22(9-10), 1006–1026.
Nikolova-Jeliazkova, N., & Jaworska, J. (2005). An approach to determining applicability domain for
QSAR group contribution models: An analysis of SRC KOWWIN. Alternatives to Laboratory Animals,
33(5), 461–470. PMID:16268758
OECD. (2004). Principles for the validation of (Q)SARs. Retrieved 31 March, 2014 from http://www.
oecd.org/dataoecd/33/37/37849783.pdf
OECD. (2007). Guidance document on the validation of (quantitative) 1226 tructure-activity relation-
ships (Q)SARs] models. ENV/JM/MONO(2007)2.
Perkins, R., Fang, H., Tong, W., & Welsh, W. J. (2003). Quantitative structure-activity relationship
methods: Perspectives on drug discovery and toxicology. Environmental Toxicology and Chemistry,
22(8), 1666–1679. doi:10.1897/01-171 PMID:12924569
Preparata, F. P., & Shamos, M. I. (1991). Computational geometry: An introduction (F. P. Preparata &
M. I. Shamos, Eds.). New York: Springer-Verlag.
Seber, G. A. F. (1984). Multivariate observations. New York: John Wiley & Sons. doi:10.1002/9780470316641
Selassie, C. D. (2003). Article. In D. J. Abraham (Ed.), Burger’s medicinal chemistry and drug discovery
(pp. 1–48). New York: John Wiley.
Sheridan, R., Feuston, R. P., Maiorov, V. N., & Kearsley, S. (2004). Similarity to molecules in the training set is a good discriminator for prediction accuracy in QSAR. Journal of Chemical Information and
Computer Sciences, 44(6), 1912–1928. doi:10.1021/ci049782w PMID:15554660
SIMCA-P 10.0. (2002). Retrieved from www.umetrics.com
Smellie, A. (2004). Accelerated K-means clustering in metric spaces. Journal of Chemical Information
and Computer Sciences, 44(6), 1929–1935. doi:10.1021/ci0499222 PMID:15554661
206
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

Importance of Applicability Domain of QSAR Models
Stanforth, R. W., Kolossov, E., & Mirkin, B. (2007). A measure of domain of applicability for QSAR
modeling based on intelligent K-means clustering. QSAR & Combinatorial Science, 26(7), 837–844.
doi:10.1002/qsar.200630086
Tetko, I. V. (2008). Associative neural network. Methods in Molecular Biology (Clifton, N.J.), 458,
185–202. doi:10.1007/978-1-60327-101-1_10 PMID:19065811
Tetko, I. V., Bruneau, P., Mewes, H. W., Rohrer, D. C., & Poda, G. I. (2006). Can we estimate the
accuracy of ADME-Tox predictions? Drug Discovery Today, 11(15-16), 700–707. doi:10.1016/j.
drudis.2006.06.013 PMID:16846797
Tetko, I. V., Sushko, I., Pandey, A. K., Zhu, H., Tropsha, A., & Papa, E. etal. (2008). Critical assessment
of QSAR models of environmental toxicity against Tetrahymena pyriformis: Focusing on applicability
domain and overfitting by variable selection. Journal of Chemical Information and Modeling, 48(9),
1733–1746. doi:10.1021/ci800151m PMID:18729318
Tetko, I. V., & Tanchuk, V. Y. (2002). Application of associative neural networks for prediction of lipophilicity in ALOGPS 2.1 program. Journal of Chemical Information and Computer Sciences, 42(5),
1136–1145. doi:10.1021/ci025515j PMID:12377001
Tong, W., Hong, H., Fang, H., Xie, Q., & Perkins, R. (2003). Decision forest: Combining the predictions
of multiple independent decision tree models. Journal of Chemical Information and Computer Sciences,
43(2), 525–531. doi:10.1021/ci020058s PMID:12653517
Tong, W., Hong, H., Xie, Q., Xie, L., Fang, H., & Perkins, R. (2004). Assessing QSAR limitations - A regulatory perspective. Current Computer-aided Drug Design, 1(2), 195–205. doi:10.2174/1573409053585663
Tong, W., Xie, Q., Hong, H., Shi, L., Fang, H., & Perkins, R. (2004). Assessment of prediction confidence and domain extrapolation of two structure–activity relationship models for predicting estrogen
receptor binding activity. Environmental Health Perspectives, 112(12), 1249–1254. doi:10.1289/ehp.7125
PMID:15345371
TOPKAT OPS. (2000). U.S. Patent 6, 036, 349, March 14, 2000. Washington, DC: US Patent Office.
Tropsha, A., Gramatica, P., & Gombar, V. K. (2003). The importance of being earnest: Validation is the
absolute essential for successful application and interpretation of QSPR models. QSAR & Combinatorial
Science, 22(1), 69–77. doi:10.1002/qsar.200390007
Walker, J. D., Jaworska, J., Comber, J. H. I., Schultz, T. W., & Dearden, J. C. (2003). Guidelines for
developing and using quantitative structure-activity relationships. Environmental Toxicology and Chem-
istry, 22(8), 1653–1665. doi:10.1897/01-627 PMID:12924568
Weaver, S., & Paul Gleeson, M. (2008). The importance of the domain of applicability in QSAR modeling. Journal of Molecular Graphics & Modelling, 26(8), 1315–1326. doi:10.1016/j.jmgm.2008.01.002
PMID:18328754
Wold, S., Sjostrom, M., & Eriksson, L. (2001). PLS-regression: A basic tool of chemometrics. Che-
mometrics and Intelligent Laboratory Systems, 58(2), 109–130. doi:10.1016/S0169-7439(01)00155-1
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
207

Importance of Applicability Domain of QSAR Models
Worth, A. P., Bassan, A., Gallegos, A., Netzeva, T. I., Patlewicz, G., & Pavan, M. etal. (2005). The
characterisation of (quantitative) structure-activity relationships: preliminary guidance. Ispra, Italy:
European Commission, Joint Research Centre.
ADDITIONAL READING
Atkinson, A. C. (1985). Plots, Transformations and Regression. Oxford: Clarendon Press.
Baskin, I. I., Kireeva, N., & Varnek, A. (2010). The one-class classification approach to data description and
to models applicability domain. Molecular Informatics, 29(8-9), 581–587. doi:10.1002/minf.201000063
berg, T. (2004). A QSAR for baseline toxicity: validation, domain of application, and prediction. Chemi-
cal Research in Toxicology, 17(12), 1630-1637.
Blekhman, I. I., & Yaroshevich, N. P. (2004). Extension of the domain of applicability of the integral
stability criterion (extremum property) in synchronization problems. Journal of Applied Mathematics
and Mechanics, 68(6), 839–846. doi:10.1016/j.jappmathmech.2004.11.005
Cronin, M. T. D., & Schultz, T. W. (2003). Pitfalls in QSAR. Journal of Molecular Structure THEO-
CHEM, 622(1-2), 39–51. doi:10.1016/S0166-1280(02)00616-4
Dearden, J. C., Cronin, M. T. D., & Kaiser, K. L. E. (2009). How not to develop a quantitative structure–
activity or structure–property relationship (QSAR/QSPR). SAR and QSAR in Environmental Research,
20(3-4), 241–266. doi:10.1080/10629360902949567 PMID:19544191
Dragos, H., Gilles, M., & Varnek, A. (2009). Predicting the predictability: A unified approach to the
applicability domain problem of QSAR models. Journal of Chemical Information and Modeling, 49(7),
1762–1776. doi:10.1021/ci9000579 PMID:19530661
Ellison, C. M., Sherhod, R., Cronin, M. T. D., Enoch, S. J., Madden, J. C., & Judson, P. N. (2011). Assessment of methods to define the applicability domain of structural alert models. Journal of Chemical
Information and Modeling, 51(5), 975–985. PMID:21488656
Eriksson, L., Jaworska, J., Worth, A., Cronin, M. T. D., McDowell, R. M., & Gramatica, P. (2003).
Methods for reliability and uncertainty assessment and for applicability evaluations of classification
and regression-based QSARs. Environmental Health Perspectives, 111(10), 1351–1375. doi:10.1289/
ehp.5758 PMID:12896860
Furusj, E., Svenson, A., Rahmberg, M., & Andersson, M. (2006). The importance of outlier detection
and training set selection for reliable environmental QSAR predictions. Chemosphere, 63(1), 99-108.
Golbraikh, A., & Tropsha, A. (2002). Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. Journal of Computer-Aided Molecular Design,
16(5-6), 357–369. doi:10.1023/A:1020869118689 PMID:12489684
Kolossov, E., & Stanforth, R. (2007). The quality of QSAR models: Problems and solutions. SAR and
QSAR in Environmental Research, 18(1), 89–100. doi:10.1080/10629360601053984 PMID:17365961
208
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

Importance of Applicability Domain of QSAR Models
Kubinyi, H. (1998). Similarity and dissimilarity: A medicinal chemist’s view. Perspectives in Drug
Discovery and Design, 9-11(0), 225–252. doi:10.1023/A:1027221424359
Kuhne, R., Ebert, R.-E., & Schuurman, G. (2009). Chemical domain of QSAR models from atomcentered fragments. Journal of Chemical Information and Modeling, 49(12), 2660–2669. doi:10.1021/
ci900313u PMID:19928752
Leonard, J. T., & Roy, K. (2006). On selection of training and test sets for the development of predictive
QSAR models. QSAR & Combinatorial Science, 25(3), 235–251. doi:10.1002/qsar.200510161
Sahlin, U., Jeliazkova, N., & Öberg, T. (2014). Applicability Domain Dependent Predictive Uncertainty
in QSAR Regressions. Molecular Informatics, 33(1), 26–35. doi:10.1002/minf.201200131
Schroeter, T. S., Schwaighofer, A., Mika, S., Laak, A. T., Suelzle, D., & Ganzer, U. etal. (2007). Estimating the domain of applicability for machine learning QSAR models: A study on aqueous solubility of
drug discovery molecules. Journal of Computer-Aided Molecular Design, 21(9), 485–498. doi:10.1007/
s10822-007-9125-z PMID:17632688
Schultz, T. W., Hewitt, M., Netzeva, T. I., & Cronin, M. T. D. (2007). Assessing Applicability Domains
of Toxicological QSARs: Definition, Confidence in Predicted Values, and the Role of Mechanisms of
Action. QSAR & Combinatorial Science, 26(2), 238–254. doi:10.1002/qsar.200630020
Schultz, T. W., Netzeva, T. I., & Cronin, M. T. (2004). Evaluation of QSARs for ecotoxicity: A method
for assigning quality and confidence. SAR and QSAR in Environmental Research, 15(5-6), 385–397. do
i:10.1080/10629360412331297344 PMID:15669697
Sheridan, R. P. (2012). Three Useful Dimensions for Domain Applicability in QSAR Models Using Random Forest. Journal of Chemical Information and Modeling, 52(3), 814–823. doi:10.1021/ci300004n
PMID:22385389
Silverman, B. W. (1986). Density Estimation for Statistics and Data Analysis. Boca Raton: CRC Press.
doi:10.1007/978-1-4899-3324-9
Soto, A. J., Vazquez, G. E., Strickert, M., & Ponzoni, I. (2011). Targetdriven subspace mapping methods and
their applicability domain estimation. Molecular Informatics, 30(9), 779–789. doi:10.1002/minf.201100053
Sushko, I., Novotarskyi, S., Körner, R., Pandey, A. K., Cherkasov, A., & Li, J. etal. (2010). Applicability
domain for classification problems: Benchmarking of distance to models for Ames mutagenicity set. Jour-
nal of Chemical Information and Modeling, 50(12), 2094–2111. doi:10.1021/ci100253r PMID:21033656
Sushko, I., Novotarskyi, S., Körner, R., Pandey, A. K., Kovalishyn, V. V., Prokopenko, V. V., & Tetko, I.
V. (2010). Applicability domain for in silico models to achieve accuracy of experimental measurements.
Journal of Chemometrics, 24(3-4), 202–208. doi:10.1002/cem.1296
Todeschini, R., Consonni, V., & Pavan, M. (2004). A distance measure between models: A tool for
similarity/diversity analysis of model populations. Chemometrics and Intelligent Laboratory Systems,
80(1), 55–61. doi:10.1016/j.chemolab.2003.10.003
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
209

Importance of Applicability Domain of QSAR Models
Toropova, A. A., & Benfenati, E. (2008). Additive SMILES-based optimal descriptors in QSAR modelling
bee toxicity: Using rare SMILES attributes to define the applicability domain. Bioorganic & Medicinal
Chemistry, 16(9), 4801–4809. doi:10.1016/j.bmc.2008.03.048 PMID:18395455
Tropsha, A. (2010). Best practices for QSAR model development, validation, and exploitation. Molecular
Informatics, 29(6-7), 476–488. doi:10.1002/minf.201000061
Tropsha, A., & Golbraikh, A. (2007). Predictive QSAR modeling workflow, model applicability domains, and
virtual screening. Current Pharmaceutical Design, 13(34), 3494–3504. doi:10.2174/138161207782794257
PMID:18220786
Walker, J. D., Jaworska, J., Comber, M. H. I., Schultz, T. W., & Dearden, J. C. (2003). Guidelines for
developing and using quantitative structure–activity relationships. Environmental Toxicology and Chem-
istry, 22(8), 1653–1665. doi:10.1897/01-627 PMID:12924568
KEY TERMS AND DEFINITIONS
3Rs: The 3Rs represent the three phrases “Reduction”, “Replacement” and “Refinement”. Replacement
corresponds to the use of non-living materials to substitute conscious living higher animals. Reduction
refers to the decrease in number of animals, and Refinement means reduction in the harshness of inhuman methodologies to be applied onto the experimental animals. In silico approaches like QSAR is an
important alternative tool to support the 3Rs approach.
Applicability Domain: The applicability domain (AD) is a theoretical region explained by physico-
chemical, structural or biological space and evaluated by the model descriptors and modeled response.
In simple explanation, AD is the knowledge or information based on which the training set of the model
is constructed, and the model is applicable to make predictions for new compounds within the specific
domain.
Multiple Linear Regression: Multiple linear regression (MLR) attempts to model the relationship
between two or more explanatory variables and a response variable by fitting a linear equation to observed data.
Partial Least Squares: Partial Least Squares (PLS) is a generalization of regression by which strongly
correlated and/or noisy or numerous X variables can be handled meticulously. The linear PLS model
finds “new variables” (which can be considered as latent variables or X scores), which are linear combinations of the original ones. To avoid the problem of overfitting, a strict test for the significance of each
consecutive PLS component is necessary and then stopping when the components are non-significant.
Principal Component Analysis: Principal Component Analysis (PCA) sums up all variation in X
into a few more informative new variables called T scores. These new variables are linearly weighted
combinations of the original X-variables. The weighting profiles are called loadings, P. For each score
variable, the influence (weight) of the original variables is found by looking at its corresponding loading profile.
210
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

Importance of Applicability Domain of QSAR Models
QSAR: Quantitative structure-activity relationship (QSAR) is a statistical modelling approach that
correlates the molecular structure to a specific activity or property or toxicity derived either in vitro or
in vivo. A simple mathematical relationship in any kind of QSAR method can be demonstrated as the
following equation: Biological activity = f (chemical structure or property). QSAR is largely used in
drug discovery, environmental fate modeling, property and biological activity prediction of new, untested
compounds from the molecular structures of compounds.
Randomization: Randomization is a validation technique which is performed in order to ensure
the robustness of the developed QSAR model. The values of the dependent variable (Y) are randomly
shuffled and new QSAR models are developed keeping the independent variable matrix unchanged.
This method is of two types: process randomization and model randomization performed at varying
confidence levels. The process is also known as Y-scrambling or Y-randomization technique.
Standard Deviation: Standard deviation (SD) can be defined as the measure of the deviation or
dispersion of a set of data from its mean. SD can be calculated as the square root of variance.
Validation: Validation is one of the backbone steps for in silico models, which includes evaluation
of issues such as data quality, robustness, predictability of the model and mechanistic interpretability in
addition to statistical judgment. Validation strategies are largely dependent on various statistical validation metrics.
Virtual Screening: Virtual screening (VS) is a computational technique used in drug discovery to
explore various existing libraries of small drug molecules in order to identify the promising structures
which are most likely to bind to a drug target, especially a protein receptor or enzyme.
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
211

212
Chapter 6
QSAR of Antioxidants
Omar Deeb
Al-Quds University, Palestine
Mohammad Goodarzi
Katholieke Universiteit Leuven, Belgium
ABSTRACT
Antioxidants are substances that protect cells from the damaging effects of oxygen radicals, which are
chemicals that play a part in some diseases such as cancer and others. Antioxidants are expected to be
promising drugs in the management of these diseases by removing oxidative stress. Most of the modeling approaches involved in designing new antioxidants is based on Quantitative Structure-Activity
Relationship (QSAR). A number of QSAR studies have been conducted to elucidate the structural requirements of antioxidants for their activities in order to predict the potency of these compounds with
regard to the targeted activity and to direct the synthesis of more potent analogues. The main focus of
this chapter is on the QSAR modeling of antioxidant compounds. The authors provide different QSAR
studies of antioxidant compounds and try to compare between them in terms of the best models obtained
and their use in designing potential new drugs.
INTRODUCTION
Generally, antioxidants are defined as molecules, which are capable of slowing down the oxidation
mechanism of an oxidizable compound. At the same time, oxidation represents an essential part of aerobic
life and our metabolism, since oxygen is the ultimate electron acceptor. Antioxidants play a significant
role in cell protection against oxidative stress. Because of the ability of antioxidants, scientific evidence
suggests that these molecules reduce the risk of chronic diseases including cancer and heart disease.
Primary sources of naturally occurring antioxidants are whole grains, fruits, vegetables etc.
Therefore, much attention has been devoted recently to research into the role of plant-derived antioxidants in food and human health. The beneficial influence of many foodstuffs and beverages including
fruits, vegetables, tea, coffee, and cacao on human health has been recently recognized to originate from
their antioxidant activity.
DOI: 10.4018/978-1-4666-8136-1.ch006
Copyright © 2015, IGI Global. Copying or distributing in print or electronic forms without written permission of IGI Global is prohibited.
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

QSAR of Antioxidants
In spite of the fact that there are many experimental techniques used to determine antioxidant activity
of a given molecule, such techniques are not only time consuming but also costly. Alternatively, using
Quantitative Structure-Activity Relationship method, one can screen a large number of compounds and
check for their potency as an antioxidant. For this purpose, the most common methods used in vitro
determination of antioxidant activity are reviewed and presented.
This chapter deals with Quantitative Structure-Activity Relationship (QSAR) of antioxidants. At first, the
definition of an antioxidant is given including it’s mechanism of action and methods of antioxidant determination. The issue of computer aided drug design is then discussed, focusing on the quantitative structure activity
relationship (QSAR). The QSAR section starts with history and the earliest efforts made in this field, types of
descriptors, statistical analysis methods from a simple linear regression such as Multiple Linear Regression
(MLR) to biased regression based on Principal Component Analysis (PCA), such as Partial Least Squares
(PLS) to nonlinear techniques such as Artificial Neural Networks (ANNs) and Support Vector Machines
(SVMs). Moreover, a part of this chapter is devoted to the validation of QSAR models, explaining the internal
and external validations. At the end, different QSAR studies of the antioxidant compounds are discussed.
These QSAR models were built on different types of compounds such as Flavonoids, Hydroxyphenylureas,
curcumin analogues, Hydroxybenzalacetones, Phenolic derivatives bearing NO donor groups and Coumarin
derivatives. Finally, it was concluded that more attention should go to the building of QSAR models for antioxidant activities in order to design more efficient drugs with potential antioxidant activity.
BACKGROUND
Antioxidants
Prior to defining what an antioxidant is, we would like to use the term oxidation as a chemical reaction which
transfers electrons or hydrogen from one substance to another. These oxidation reactions can produce free
radicals, which are unstable molecules that lose one of their electrons and therefore become unbalanced and
highly reactive. These unstable molecules can then start chain reactions in a cell and therefore, may cause
damage or result in death of these cells. These free radicals are free moving compounds that travel around
the body trying to become stable by taking electrons from healthy compounds. Further free radicals are
formed after a successful steal, damaging healthy cells in the progression. These free radicals are the main
reason behind heart disease, cancer, aging and other diseases. Therefore, an antioxidant is a substance that
inhibits the oxidation of other molecules and terminates the chain reactions by removing the free radicals
and inhibiting other oxidation reactions. In other words, an antioxidant is a stable molecule that donates an
electron to a free radical neutralizing it and therefore, reducing its capability to damage other cells.
Antioxidants are extensively used as ingredients in dietary supplements with the hope of maintaining
health and preventing diseases. At the same time, these antioxidants have many industrial uses such as
preservatives in food and cosmetics, and preventing the degradation of rubber. As is known, antioxidants
are abundant in fruits and vegetables. Examples of antioxidants that are formed during metabolism in
the body, or endogenous antioxidants (Enzymes), are glutathione, ubiquinol, uric acid etc. Some antioxidants are present in the diet while others must be supplied in the diet such as vitamin C, vitamin E
and others. In this case, they are called exogenous antioxidants and can be derived from natural sources
but also can be synthesized compounds (Benzie, 2003; Knight, 1998; Matill, 1947; Sies, 1997; Valko,
Leibfritz, Moncol, Cronin, Mazur & Telser, 2007; Vertuani, Angusti & Manfredini, 2004; Wolf, 2005)
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
213

QSAR of Antioxidants
+ → +
→ +
Recently, antioxidants have attracted extensive attention in relation to radicals and oxidative stress,
cancer prophylaxis and therapy. Phenols and polyphenols are the target analysis in numerous such cases;
they may be detected by enzymes like tyrosinase or other phenol oxidases, or even by plant tissues containing these enzymes. The recommendations based on epidemiological studies are that fruits, vegetables and
less processed fast foods guarantee the best defense against the increase of diseases caused by oxidative
stress, such as cancer, hypertension and others. The elucidation consists in the valuable health effect,
owing to antioxidants present in fruit and vegetables. There are numerous antioxidants in dietary plants
such as: phenolic compounds, benzoic acid derivatives and flavonoids. (Halvorsen, Carlsen, Phillips,
Bohn & Holte, 2006; Halvorsen, Holte, Myhrstad, Barikmo & Hvattum, 2002)
MECHANISM OF ACTION OF ANTIOXIDANTS
Two main mechanisms have been proposed regarding the mechanism of action of antioxidants. The first
one is related to chain breaking in which the main antioxidant donates an electron to the free radical,
which exists in the system, while the second mechanism involves the removal of reactive oxygen/nitrogen
species initiators (ROS/RNS). The mechanism of action can be summarized as: Initiation, Propagation,
Branching and Termination (Antolovic, Prenzler, Patsalides, McDonald & Robards, 2002)
The antioxidants in the defense systems act at different levels: preventive antioxidants which suppress
the formation of free radicals, antioxidants that scavenge the active radicals to suppress chain initiation
or breaking, the repair and de novo antioxidants.
In the initiation step, a substrate molecule (SH) such as lipid reacts with the initiating oxidizing radical (R.) and a highly reactive allyl radical (S.) is produced as in the following equation:
SH R S RH+ → +. . (1)
In the propagation step, the allyl radical (S.) reacts quickly with oxygen to produce a lipid peroxyl
radical (SOO.). This allyl peroxyl radical (SOO.) can further oxidize the substrate molecule producing
lipid hydroperoxides (SOOH) as shown in the following Equations (2 and 3:
S O SOO. .+ →
2
SOO SH S SOOH. .
(2)
(3)
In the branching step, the lipid hydroperoxides (SOOH) can break down to alcohols, aldehydes, ketones and others including alkoxyl radical (SO.), which can be seen in the following Equations (4 and 5:
SOOH SO HO . .
(4)
22SOOH SOO SO H O . . → + + (5)
214
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use

+ → +
QSAR of Antioxidants
In the termination step, combination of radicals will produce non-radical products as is shown below:
SO SO. .+
SOO SOO. .+
SO SOO. .+
The primary antioxidant (AntiH) delay or inhibit the initiation step by reacting with a substrate radical or inhibit the propagation step by reacting with peroxyl or alkoxyl radicals as shown in the following
Equations (6, 7, and 8):
S AntiH SH Anti. .
(6)
SOO AntiH SOOH Anti. .+ → + (7)
SO AntiH SOH Anti. .+ → + (8)
While the secondary or preventive antioxidant slow down, the speed of oxidation by taking away
from the substrate or singlet oxygen increases.
In order to illustrate the mechanism of action of antioxidants, in the initiation step (Equation 1),
the flavonoids (ROH) is as a substrate that can react with initiating oxidizing free radical (DPPH.) to
produce flavonoid phenoxyl radical (RO.) and DPPHH. Another example is the reaction of a reduced
glutathione molecule (GSH) with hydroxyl radical (OH.), which produces glutathione radical (GS.) and
a water molecule (H
a hydrogen atom to a free radical molecule (R.) to neutralize it and produce an ascorbate radical Asc.
O). Vitamine C is also another example, Ascorbate AscH- for instance can donate
2
-
METHODS OF ANTIOXIDANTS DETERMINATION
There are various analytical techniques used to determine total antioxidant activity. These techniques
are mainly based on spectrometric, electrochemical and Chromatographic techniques. The spectrometric
techniques depend on the reaction of a radical, radical cation or complex with an antioxidant molecule
capable of donating a hydrogen atom. An example of the spectrometric methods is the DPPH method.
The DPPH (2,2-diphenyl-1-picrylhydrazyl) is a stable free radical because of the delocalization of the
spare electron on the whole molecule. This delocalization determines the occurrence of purple color at
an absorption band of 520nm. When DPPH reacts with a hydrogen donor, a molecular form of DPPH
is formed accompanied with the vanishing of the color. So the absorbance decrease depends linearly
on the antioxidant concentration (Pisoschi, Cheregi & Danet, 2009; Thaipong, Boonprakob, Crosby,
Cisneros-Zevallos & Byrne, 2006)
EBSCOhost - printed on 2/14/2023 7:16 AM via . All use subject to https://www.ebsco.com/terms-of-use
215
Соседние файлы в папке Библиотека им академика М.И. Перельмана
